CPAP Devices Can Be Used as Ventilators During Coronavirus Outbreak, FDA Guidance Says

Published in Member Communities on March 24, 2020

On March 22, it was announced that new temporary guidance from the FDA allows hospitals to re-purpose existing products such as CPAP devices as ventilators in an effort to meet major shortages in the United States during the coronavirus outbreak.

The guidance allows hospitals and manufacturers to make certain modifications to existing devices, or to production lines, to create more respiratory devices.

Ventilators normally used in other environments, such as ambulances, could be used for long-term care, the guidance says. It covers devices that aren't traditionally used for long-term care.

The guidance also would allow non-medical device companies, such as auto manufacturers, to start making ventilator parts.

The agency plans to use "enforcement discretion" for modifications to FDA-cleared devices. Traditionally manufacturers' modifications to ventilators would trigger an additional pre-market review, which could delay deployment.

The guidance means "America can make more ventilators during this crisis,” Health and Human Services Secretary Alex Azar said in a release.

The guidance also aims to create "maximum regulatory flexibility" while "still providing crucial FDA oversight," FDA Commissioner Stephen Hahn said in a release.

FDA is also encouraging manufacturers, including foreign ones, to contact the agency about emergency authorizations to distribute ventilators in the United States.

Original Updates:

 

From Our Experts

Member Spotlight: Chris Moore & the Power of “Age Out Loud” thumbnail Member Spotlight: Chris Moore & the Power of “Age Out Loud” VGM Live at Home spotlights Chris Moore, whose book Age Out Loud and passion for CAPS training inspire professionals to help more people age safely at home. Introducing the F&P Nova Nasal in the United States thumbnail Introducing the F&P Nova Nasal in the United States Fisher and Paykel Healthcare has announced the launch of their newest nasal PAP mask, F&P Nova Nasal, to the United States, for the treatment of obstructive sleep apnea. A Note from the President: VGM is Evolving For You thumbnail A Note from the President: VGM is Evolving For You VGM is evolving with purpose by investing in advocacy, technology, and services to support HME providers through industry change and ensure long-term viability. Introducing the F&P Nova Nasal in the United States thumbnail Introducing the F&P Nova Nasal in the United States Fisher and Paykel Healthcare has announced the launch of their newest nasal PAP mask, F&P Nova Nasal, to the United States, for the treatment of obstructive sleep apnea. Member Spotlight: Browning's Pharmacy and Health Care thumbnail Member Spotlight: Browning's Pharmacy and Health Care Browning's Pharmacy and Health Care: Longtime VGM HME provider since 1987, delivering quality home medical equipment, pharmacy services, and patient support. Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard thumbnail Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard Discover how integrated sleep programs help providers cut OSA screening-to-treatment timelines to 30 days while improving patient outcomes. Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard thumbnail Integrated Sleep Programs in 2026: Faster OSA Care is the New Standard Discover how integrated sleep programs help providers cut OSA screening-to-treatment timelines to 30 days while improving patient outcomes. 2026 HME Woman of the Year Award Nominations Open Now thumbnail 2026 HME Woman of the Year Award Nominations Open Now Submit nominations for the 2026 HME Woman of the Year Award. Recognize top women leaders in HME, DME, and CRT. Winner announced at Heartland Conference 2026.